Clinical Trial Update: Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating gemcitabine with PEGPH20 versus gemcitabine alone in stage IV pancreatic cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PEGPH20 (pegylated hyaluronidase)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Stage IV Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-11-30